BMO Capital Keeps Arena Pharma (ARNA) at 'Market Perform' Following BELVIQ Combo Update
Tweet Send to a Friend
BMO Capital affirms Arena Pharmaceuticals, Inc. (ARNA) at Market Perform with a price target of $8 after the company reported ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE